These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
482 related articles for article (PubMed ID: 17323019)
1. [Intraepithelial neoplasms (PanIN) and intraductal papillary-mucinous neoplasms (IPMN) of the pancreas as precursor lesions of pancreatic carcinoma]. Ott C; Heinmöller E; Gaumann A; Schölmerich J; Klebl F Med Klin (Munich); 2007 Feb; 102(2):127-35. PubMed ID: 17323019 [TBL] [Abstract][Full Text] [Related]
2. Serine protease inhibitor Kazal type 1 and epidermal growth factor receptor are expressed in pancreatic tubular adenocarcinoma, intraductal papillary mucinous neoplasm, and pancreatic intraepithelial neoplasia. Ozaki N; Ohmuraya M; Ida S; Hashimoto D; Ikuta Y; Chikamoto A; Hirota M; Baba H J Hepatobiliary Pancreat Sci; 2013 Aug; 20(6):620-7. PubMed ID: 23475261 [TBL] [Abstract][Full Text] [Related]
3. Differential ezrin and phosphorylated ezrin expression profiles between pancreatic intraepithelial neoplasia, intraductal papillary mucinous neoplasm, and invasive ductal carcinoma of the pancreas. Oda Y; Aishima S; Morimatsu K; Hayashi A; Shindo K; Fujino M; Mizuuchi Y; Hattori M; Tanaka M; Oda Y Hum Pathol; 2013 Aug; 44(8):1487-98. PubMed ID: 23465281 [TBL] [Abstract][Full Text] [Related]
4. Distinct progression pathways involving the dysfunction of DUSP6/MKP-3 in pancreatic intraepithelial neoplasia and intraductal papillary-mucinous neoplasms of the pancreas. Furukawa T; Fujisaki R; Yoshida Y; Kanai N; Sunamura M; Abe T; Takeda K; Matsuno S; Horii A Mod Pathol; 2005 Aug; 18(8):1034-42. PubMed ID: 15832194 [TBL] [Abstract][Full Text] [Related]
8. Where and when does pancreatic carcinoma start? Lüttges J; Hahn S; Klöppel G Med Klin (Munich); 2004 Apr; 99(4):191-5. PubMed ID: 15085289 [TBL] [Abstract][Full Text] [Related]
9. Ductal neoplasia of the pancreas: nosologic, clinicopathologic, and biologic aspects. Adsay NV; Basturk O; Cheng JD; Andea AA Semin Radiat Oncol; 2005 Oct; 15(4):254-64. PubMed ID: 16183479 [TBL] [Abstract][Full Text] [Related]
10. hsa-miR-96 and hsa-miR-217 Expression Down-Regulates with Increasing Dysplasia in Pancreatic Intraepithelial Neoplasias and Intraductal Papillary Mucinous Neoplasms. Chang X; Yu C; Li J; Yu S; Chen J Int J Med Sci; 2017; 14(5):412-418. PubMed ID: 28539816 [No Abstract] [Full Text] [Related]
11. Clinicopathological features of pancreatic intraepithelial neoplasias and their relationship to intraductal papillary-mucinous tumors. Takaori K; Kobashi Y; Matsusue S; Matsui K; Yamamoto T J Hepatobiliary Pancreat Surg; 2003; 10(2):125-36. PubMed ID: 14505145 [TBL] [Abstract][Full Text] [Related]